Thursday, December 26, 2024
name of Prensa Latina
Bandera inglesa
English Edition
Search
Close this search box.
name of Prensa Latina

NEWS

trials

Beijing, Aug 13 (Prensa Latina) The Cuba-China Biotech Pharmaceuticals Limited (BPL) joint venture is getting ready today to begin clinical trials here of the monoclonal antibody Itolizumab, of Cuban patent, which is used against autoimmune diseases.
Havana, Aug 2 (Prensa Latina) Cuba is developing its first transcutaneous electrostimulation device of the vagus nerve to treat drug-resistant epilepsy, it was announced on Friday.
New Delhi, Mar 26 (Prensa Latina) India began clinical trials of a vaccine against tuberculosis by the Spanish biopharmaceutical company Biofabri in adults with human immunodeficiency virus (HIV), it was reported here.
Havana, Mar 3 (Prensa Latina) Cuban scientists began the preclinical studies with tests of two formulations of the vaccine candidate against dengue, the Center for Genetic Engineering and Biotechnology (CIGB) reported on its Twitter account on Monday.
Havana, Mar 28 (Prensa Latina) NeuroEPO, Cuba's neuroprotective drug to counteract mild and moderate Alzheimer's disease, concluded phase II/III studies and a stage IV of progressive introduction of the product is being prepared, a scientific authority noted on Monday.
Havana, Mar 22 (Prensa Latina) President Miguel Diaz-Canel on Tuesday highlighted the work of Cuban legal professionals, in the face of media attacks for their actions in proceedings against the participants in the 2021 riots in several cities in the country.
Rome, Mar 11 (Prensa Latina) A delegation from Cuba's Finlay Vaccines Institute (IFV), headed by its general director, Dr. Vicente Verez, left on Friday for France and expressed satisfaction with the results of a week-long stay in Italy.
Havana, Feb 14 (Prensa Latina) The lawyers representing those involved in the criminal proceedings arising from the riots that took place in Cuba in July 11 and 12, 2021, assured that constitutional guarantees have been respected during the trials.